Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Arthritis as a Manifestation of Systemic Disease Follow-up

  • Author: Ritu Khurana, MD; Chief Editor: Herbert S Diamond, MD  more...
 
Updated: Nov 10, 2014
 

Prognosis

In general, therapy to manage the underlying illness results in improvement or complete resolution of the joint manifestations. Acute sarcoid arthritis does not cause joint damage.

In contrast, most patients with acromegaly have had the disease for many years prior to diagnosis and are left with cartilage hypertrophy and severe degenerative joint disease. The arthritis of hemochromatosis does not improve with phlebotomy.

Next

Patient Education

For patient education resources, see the Arthritis Center and Muscle Disorders Center, as well as Knee Pain.

Previous
 
Contributor Information and Disclosures
Author

Ritu Khurana, MD Chief of Rheumatology, Crozer Chester Medical Center, Upland, PA

Ritu Khurana, MD is a member of the following medical societies: American College of Physicians, American College of Rheumatology, International Society for Clinical Densitometry

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Lawrence H Brent, MD Associate Professor of Medicine, Jefferson Medical College of Thomas Jefferson University; Chair, Program Director, Department of Medicine, Division of Rheumatology, Albert Einstein Medical Center

Lawrence H Brent, MD is a member of the following medical societies: American Association for the Advancement of Science, American Association of Immunologists, American College of Physicians, American College of Rheumatology

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Janssen<br/>Serve(d) as a speaker or a member of a speakers bureau for: Abbvie; Genentech; Pfizer; Questcor.

Chief Editor

Herbert S Diamond, MD Visiting Professor of Medicine, Division of Rheumatology, State University of New York Downstate Medical Center; Chairman Emeritus, Department of Internal Medicine, Western Pennsylvania Hospital

Herbert S Diamond, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians, American College of Rheumatology, American Medical Association, Phi Beta Kappa

Disclosure: Nothing to disclose.

Additional Contributors

Kristine M Lohr, MD, MS Professor, Department of Internal Medicine, Interim Chief, Division of Rheumatology, Director, Rheumatology Training Program, University of Kentucky College of Medicine

Kristine M Lohr, MD, MS is a member of the following medical societies: American College of Physicians, American College of Rheumatology

Disclosure: Nothing to disclose.

Acknowledgements

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous authors R Hal Scofield, MD and Linda A Zacharias, MD to the development and writing of this article.

References
  1. Nell-Duxneuner V, Axmann R, Husar-Memmer E, Dallos T, Datz C, Stadlmayr A, et al. VCAM-1 serum levels are associated with arthropathy in hereditary haemochromatosis. Ann Rheum Dis. 2013 Dec. 72(12):2006-10. [Medline].

  2. Diabetes Home: 2014 Statistics Report. Centers for Disease Control and Prevention. Available at http://www.cdc.gov/diabetes/data/statistics/2014StatisticsReport.html. Accessed: November 3, 2014.

  3. Helfand M, Crapo LM. Screening for thyroid disease. Ann Intern Med. 1990 Jun 1. 112(11):840-9. [Medline].

  4. Cagliero E, Apruzzese W, Perlmutter GS, Nathan DM. Musculoskeletal disorders of the hand and shoulder in patients with diabetes mellitus. Am J Med. 2002 Apr 15. 112(6):487-90. [Medline].

  5. Fam AG. Paraneoplastic rheumatic syndromes. Baillieres Best Pract Res Clin Rheumatol. 2000 Sep. 14(3):515-33. [Medline].

  6. [Guideline] Bacon BR, Adams PC, Kowdley KV, Powell LW, Tavill AS. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology. 2011 Jul. 54(1):328-43. [Medline]. [Full Text].

  7. Boswell SB, Patel DB, White EA, Gottsegen CJ, Forrester DM, Masih S, et al. Musculoskeletal manifestations of endocrine disorders. Clin Imaging. 2014 Jul-Aug. 38(4):384-96. [Medline].

  8. Cagliero E, Apruzzese W, Perlmutter GS, Nathan DM. Musculoskeletal disorders of the hand and shoulder in patients with diabetes mellitus. Am J Med. 2002 Apr 15. 112(6):487-90. [Medline].

  9. Carlsson A. Hereditary hemochromatosis: a neglected diagnosis in orthopedics: a series of 7 patients with ankle arthritis, and a review of the literature. Acta Orthop. 2009 Jun. 80(3):371-4. [Medline]. [Full Text].

  10. Crispin JC, Alcocer-Varela J. Rheumatologic manifestations of diabetes mellitus. Am J Med. 2003 Jun 15. 114(9):753-7. [Medline].

  11. Diamond T, Stiel D, Posen S. Osteoporosis in hemochromatosis: iron excess, gonadal deficiency, or other factors?. Ann Intern Med. 1989 Mar 15. 110(6):430-6. [Medline].

  12. Dorwart BB, Schumacher HR. Joint effusions, chondrocalcinosis and other rheumatic manifestations in hypothyroidism. A clinicopathologic study. Am J Med. 1975 Dec. 59(6):780-90. [Medline].

  13. Faraawi R, Harth M, Kertesz A, Bell D. Arthritis in hemochromatosis. J Rheumatol. 1993 Mar. 20(3):448-52. [Medline].

  14. Golding DN. Rheumatism and the thyroid. J R Soc Med. 1993 Mar. 86(3):130-2. [Medline]. [Full Text].

  15. Jacobs-Kosmin D, DeHoratius RJ. Musculoskeletal manifestations of endocrine disorders. Curr Opin Rheumatol. 2005 Jan. 17(1):64-9. [Medline].

  16. Jordan JM. Arthritis in hemochromatosis or iron storage disease. Curr Opin Rheumatol. 2004 Jan. 16(1):62-6. [Medline].

  17. Kaminski HJ. Endocrine myopathies. Myology. 1994: 1741-2.

  18. Kapur S, McKendry RJ. Treatment and outcomes of diabetic muscle infarction. J Clin Rheumatol. 2005 Feb. 11(1):8-12. [Medline].

  19. Khachadurian AK. Migratory polyarthritis in familial hypercholesterolemia (type II hyperlipoproteinemia). Arthritis Rheum. 1968 Jun. 11(3):385-93. [Medline].

  20. Klein I, Parker M, Shebert R, Ayyar DR, Levey GS. Hypothyroidism presenting as muscle stiffness and pseudohypertrophy: Hoffmann's syndrome. Am J Med. 1981 Apr. 70(4):891-4. [Medline].

  21. Klemp P, Halland AM, Majoos FL, Steyn K. Musculoskeletal manifestations in hyperlipidaemia: a controlled study. Ann Rheum Dis. 1993 Jan. 52(1):44-8. [Medline]. [Full Text].

  22. Lacks S, Jacobs RP. Acromegalic arthropathy: a reversible rheumatic disease. J Rheumatol. 1986 Jun. 13(3):634-6. [Medline].

  23. Lieberman SA, Bjorkengren AG, Hoffman AR. Rheumatologic and skeletal changes in acromegaly. Endocrinol Metab Clin North Am. 1992 Sep. 21(3):615-31. [Medline].

  24. McGuire JL. The endocrine system and connective tissue disorders. Bull Rheum Dis. 1990. 39(4):1-8. [Medline].

  25. McLean RM, Podell DN. Bone and joint manifestations of hypothyroidism. Semin Arthritis Rheum. 1995 Feb. 24(4):282-90. [Medline].

  26. Olynyk J, Hall P, Ahern M, Kwiatek R, Mackinnon M. Screening for genetic haemochromatosis in a rheumatology clinic. Aust N Z J Med. 1994 Feb. 24(1):22-5. [Medline].

  27. Smith LL, Burnet SP, McNeil JD. Musculoskeletal manifestations of diabetes mellitus. Br J Sports Med. 2003 Feb. 37(1):30-5. [Medline]. [Full Text].

Previous
Next
 
This picture shows a 42-year-old white man who was admitted with acute back pain. In this frontal view, note the lower-face fullness that obscures his ears and the plethora of his cheeks.
Focal osteolytic changes seen in the phalanges in a patient with chronic sarcoid arthritis.
Osteolysis has left a lacy trabecular pattern in this phalanx (arrow).
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.